{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:58:15Z","timestamp":1793732295397,"version":"4.6.1"},"reference-count":51,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Aging Mind Foundation Dallas and Baylor Scott &amp; White Foundation, Dallas, Texas.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Disruptions in one-carbon metabolism and elevated homocysteine have been previously implicated in the development of dementia associated with Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD). Moreover, a PD diagnosis itself carries substantial risk for the development of dementia. This is the first study that explores alterations in one-carbon metabolism in AD and PD directly in the human brain frontal cortex, the primary center of cognition. Applying targeted liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS), we analyzed post-mortem samples obtained from 136 subjects (35 AD, 65 PD, 36 controls). We found changes in one-carbon metabolites that indicate inefficient activation of cystathionine \u03b2-synthase (CBS) in AD and PD subjects with dementia, the latter seemingly accompanied by a restricted re-methylation flow. Levodopa\u2013carbidopa is known to reduce available vitamin B6, which would explain the hindered CBS activity. We present evidence of temporary non-protein-bound homocysteine accumulation upon levodopa intake in the brain of PD subjects with dementia but not in non-demented PD subjects. Importantly, this homocysteine elevation is not related to levodopa dosage, disease progression, or histopathological markers but exclusively to the dementia status. We hypothesize that this levodopa-induced effect is a direct cause of dementia in PD in susceptible subjects with reduced re-methylation capacity. Furthermore, we show that betaine best correlates with cognitive score even among PD subjects alone and discuss nutritional recommendations to improve one-carbon metabolism function.<\/jats:p>","DOI":"10.3390\/nu14030599","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T00:12:56Z","timestamp":1643501576000},"page":"599","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["One-Carbon Metabolism in Alzheimer\u2019s Disease and Parkinson\u2019s Disease Brain Tissue"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-6811","authenticated-orcid":false,"given":"Karel","family":"Kaleck\u00fd","sequence":"first","affiliation":[{"name":"Institute of Biomedical Studies, Baylor University, Waco, TX 76712, USA"},{"name":"Center of Metabolomics, Institute of Metabolic Disease, Baylor Scott & White Research Institute, Dallas, TX 75204, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ashcraft","sequence":"additional","affiliation":[{"name":"Center of Metabolomics, Institute of Metabolic Disease, Baylor Scott & White Research Institute, Dallas, TX 75204, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4199-7551","authenticated-orcid":false,"given":"Teodoro","family":"Bottiglieri","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Studies, Baylor University, Waco, TX 76712, USA"},{"name":"Center of Metabolomics, Institute of Metabolic Disease, Baylor Scott & White Research Institute, Dallas, TX 75204, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00726-006-0432-9","article-title":"Mechanisms of homocysteine toxicity in humans","volume":"32","author":"Twardowski","year":"2007","journal-title":"Amino Acids"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.55782\/ane-2006-1619","article-title":"Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: The role of NMDA and group I metabotropic glutamate receptors","volume":"66","author":"Zieminska","year":"2006","journal-title":"Acta Neurobiol. Exp. Wars"},{"key":"ref_3","first-page":"10","article-title":"Clinical and laboratory features of homocystinuria","volume":"19","author":"Cacciari","year":"1989","journal-title":"Haemostasis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.hjr.0000160834.75466.b0","article-title":"Serum homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study","volume":"12","author":"Virtanen","year":"2005","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e19467","DOI":"10.1097\/MD.0000000000019467","article-title":"The association between homocysteine and ischemic stroke subtypes in Chinese: A meta-analysis: A meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"ref_9","first-page":"42","article-title":"Plasma homocysteine in Alzheimer\u2019s disease with or without co-morbid depressive symptoms","volume":"35","author":"Fisar","year":"2014","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/WNL.56.6.730","article-title":"Risk of dementia in Parkinson\u2019s disease: A community-based, prospective study","volume":"56","author":"Aarsland","year":"2001","journal-title":"Neurology"},{"key":"ref_11","first-page":"9539836","article-title":"Parkinson\u2019s disease and homocysteine: A community-based study in a folate and vitamin B12 deficient population","volume":"2016","author":"Wei","year":"2016","journal-title":"Parkinsons Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/aje\/kwh213","article-title":"Folate intake and risk of Parkinson\u2019s disease","volume":"160","author":"Chen","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.wnl.0000225050.57553.6d","article-title":"Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease","volume":"67","author":"Koudstaal","year":"2006","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/mds.20253","article-title":"Modest increase in plasma homocysteine follows levodopa initiation in Parkinson\u2019s disease","volume":"19","author":"Bottiglieri","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.parkreldis.2014.06.006","article-title":"Predictors of dementia in Parkinson\u2019s disease; findings from a 5-year prospective study using the SCOPA-COG","volume":"20","author":"Zhu","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/mds.27301","article-title":"Parkinson Study Group-DATATOP Investigators Vitamin B12 and homocysteine levels predict different outcomes in early Parkinson\u2019s disease","volume":"33","author":"Christine","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3233\/JAD-2010-1311","article-title":"Reduced homocysteine-thiolactonase activity in Alzheimer\u2019s disease","volume":"19","author":"Suszynska","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00702-003-0096-5","article-title":"Elevated S-adenosylhomocysteine in Alzheimer brain: Influence on methyltransferases and cognitive function","volume":"111","author":"Kennedy","year":"2004","journal-title":"J. Neural Transm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","article-title":"Arizona Study of Aging and Neurodegenerative Disorders and brain and Body Donation Program: Arizona brain and body donation program","volume":"35","author":"Beach","year":"2015","journal-title":"Neuropathology"},{"key":"ref_20","unstructured":"The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u2019s Disease (1997). Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease. Neurobiol. Aging, 18, S1\u2013S2."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jchromb.2018.06.008","article-title":"Simultaneous measurement of folate cycle intermediates in different biological matrices using liquid chromatography-tandem mass spectrometry","volume":"1092","author":"Nandania","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Garg, U. (2016). Clinical Applications of Mass Spectrometry in Biomolecular Analysis: Methods and Protocols, Humana Press.","DOI":"10.1007\/978-1-4939-3182-8"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Fox, J., and Weisberg, S. (2018). An R Companion to Applied Regression, SAGE Publications. [3rd ed.].","DOI":"10.32614\/CRAN.package.carData"},{"key":"ref_24","unstructured":"Tukey, J.W. (1977). Exploratory Data Analysis, Addison-Wesley."},{"key":"ref_25","unstructured":"Pinheiro, J., Bates, D., DebRoy, S., and Sarkar, D. (2021, September 01). R Core Team. nlme: Linear and Nonlinear Mixed Effects Models. In The Comprehensive R Archive Network; R Package Version 3.1-152. Available online: https:\/\/CRAN.R-project.org\/package=nlme."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hao, X., Huang, Y., Qiu, M., Yin, C., Ren, H., Gan, H., Li, H., Zhou, Y., Xia, J., and Li, W. (2016). Immunoassay of S-adenosylmethionine and S-adenosylhomocysteine: The methylation index as a biomarker for disease and health status. BMC Res. Notes, 9.","DOI":"10.1186\/s13104-016-2296-8"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20120731","article-title":"Human cystathionine \u03b2-synthase (CBS) contains two classes of binding sites for S-adenosylmethionine (SAM): Complex regulation of CBS activity and stability by SAM","volume":"449","author":"Pey","year":"2013","journal-title":"Biochem. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1212\/WNL.58.10.1471","article-title":"Homocysteine, vitamin B6, and vascular disease in AD patients","volume":"58","author":"Miller","year":"2002","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/1567205043332243","article-title":"Cystathionine beta synthase as a risk factor for Alzheimer disease","volume":"1","author":"Beyer","year":"2004","journal-title":"Curr. Alzheimer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0006-291X(02)00422-9","article-title":"Brain hydrogen sulfide is severely decreased in Alzheimer\u2019s disease","volume":"293","author":"Eto","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archneurol.2010.38","article-title":"Reduced lean mass in early Alzheimer disease and its association with brain atrophy","volume":"67","author":"Burns","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e22090","DOI":"10.1002\/jcla.22090","article-title":"Association between malnutrition and hyperhomocysteine in Alzheimer\u2019s disease patients and diet intervention of betaine","volume":"31","author":"Sun","year":"2017","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1212\/WNL.39.4.549","article-title":"The effect of dietary protein on the efficacy of L-dopa: A double-blind study","volume":"39","author":"Tsui","year":"1989","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0065-2571(82)90012-7","article-title":"Modulation of methylenetetrahydrofolate reductase activity by S-adenosylmethionine and by dihydrofolate and its polyglutamate analogues","volume":"20","author":"Matthews","year":"1982","journal-title":"Adv. Enzyme Regul."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0006-291X(84)91060-X","article-title":"Inactivation of betaine-homocysteine methyltransferase by adenosylmethionine and adenosylethionine","volume":"118","author":"Finkelstein","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1017\/S0007114510001005","article-title":"Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson\u2019s disease: A case-control study in Japan","volume":"104","author":"Murakami","year":"2010","journal-title":"Br. J. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WNF.0000000000000408","article-title":"Vitamin B6 deficiency in patients with Parkinson disease treated with levodopa\/carbidopa","volume":"43","year":"2020","journal-title":"Clin. Neuropharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1212\/01.WNL.0000055899.24594.8E","article-title":"Effect of L-dopa on plasma homocysteine in PD patients: Relationship to B-vitamin status","volume":"60","author":"Miller","year":"2003","journal-title":"Neurology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0026-0495(78)90211-1","article-title":"Effect of pyridoxine on the depletion of tissue pyridoxal phosphate by carbidopa","volume":"27","author":"Airoldi","year":"1978","journal-title":"Metabolism"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mdc3.12688","article-title":"Levodopa-induced neuropathy: A systematic review: Levodopa-induced neuropathy","volume":"6","author":"Romagnolo","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_45","first-page":"D2818","article-title":"Vitamin B6 deficiency caused by the use of levodopa","volume":"162","author":"Groen","year":"2018","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fimmu.2018.01070","article-title":"Betaine in inflammation: Mechanistic aspects and applications","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2019.01.043","article-title":"Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt\/mTOR signaling in methionine-choline deficiency-induced fatty liver disease","volume":"848","author":"Veskovic","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_48","first-page":"950","article-title":"Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats","volume":"18","author":"Alirezaei","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/1673-5374.265543","article-title":"Protective effect of hydrogen sulfide on oxidative stress-induced neurodegenerative diseases","volume":"15","author":"Tabassum","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/ncomms2623","article-title":"Sulfhydration mediates neuroprotective actions of parkin","volume":"4","author":"Vandiver","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.7150\/ijms.36516","article-title":"Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases","volume":"16","author":"Tabassum","year":"2019","journal-title":"Int. J. Med. Sci."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/3\/599\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:10:53Z","timestamp":1760134253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/3\/599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["nu14030599"],"URL":"https:\/\/doi.org\/10.3390\/nu14030599","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]}}}